Recent advance in mesenchymal stem cell exosome in Alzheimer's disease
10.3760/cma.j.cn115354-20240924-00591
- VernacularTitle:间充质干细胞外泌体在阿尔茨海默病中的研究进展
- Author:
Shijun HU
1
;
Yumeng LI
;
Tao LIU
Author Information
1. 海南医科大学附属海南医院,海南省人民医院神经内科,海口 570311
- Publication Type:Journal Article
- Keywords:
Alzheimer's disease;
Mesenchymal stem cell-derived exosome;
Mesenchymal stem cell;
Nano-drug;
Engineered exosome;
Therapeutic mechanism
- From:
Chinese Journal of Neuromedicine
2025;24(2):201-206
- CountryChina
- Language:Chinese
-
Abstract:
Alzheimer's disease (AD) is the leading neurodegenerative disorder in the nervous system, and there is still a lack of effective therapeutic drugs. Protecting neurons and synapses is crucial in reversing AD progression. Mesenchymal stem cell-derived exosome (MSC-Exo) is rich in various stem cell components such as proteins, RNAs, and DNAs; due to its strong ability in promoting nerve repair and inhibiting neuroinflammation, MSC-Exo is expected to become a potential choice for AD treatment. This article elaborates on the biological characteristics of MSC-Exo and its application and progress in AD treatment, aiming to provide reference for translational medicine research and clinical application of MSC-Exo in AD.